1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Ascites - Epidemiology Forecast - 2030

Ascites - Epidemiology Forecast - 2030

  • January 2021
  • 70 pages
  • ID: 6025282
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Ascites—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Ascites epidemiology in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.
Ascites Understanding
Ascites (hydroperitoneum is a rare synonym) is defined as an abnormal amount of intraperitoneal fluid. Ascites is a condition in which fluid collects in spaces within the abdomen. If severe, ascites may be painful. The problem may keep the patient from moving around comfortably. Fluid may also move into the chest and surround the lungs. This condition can make eating, drinking, and moving around difficult. It can also make it hard to breathe. Ascites can lead to abdominal infections, which may cause kidney failure and can also cause umbilical or inguinal hernias.
Ascites is common in patients with cirrhosis and usually develops when their liver is beginning to fail. The elevation of the pressure in the veins that run through the liver (portal hypertension) and a decrease in liver function due to the scarring on the liver result in the fluid build-up.

Ascites Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Number of Ascites Cases due to Cirrhosis, Number of Ascites Cases by Malignancies, and Severity-specific Cases of Ascites due to Cirrhosis scenario of Ascites in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030.

Ascites Detailed Epidemiology Segmentation
• In 2020, the total cases of Ascites due to cirrhosis in the 7MM was 240,730, which is likely to increase by 2030 at a CAGR of 0.61% for the study period (2018–2030).
• Malignant Ascites cases are calculated from ovarian cancer, stomach cancer, breast cancer, and colorectal cancer. In 2020, The number of cases of Ascites from these cancers was 8,521; 3,538; 12,650; and 10,276, respectively, in the US.
• According to the analysis, in 2020, there were 26,841 and 122,277 cases of Grade I and Grade II & III ascites due to cirrhosis in the United States.
• Among the EU-5 countries, the highest cases of Ascites due to cirrhosis were found in Germany (20,004), followed by the UK (15,845) and France (11,138). The least cases of Ascites due to cirrhosis were found in Spain (4,904).
• There were 29,571 cases of ascites due to cirrhosis in Japan in 2020.

Scope of the Report
• The report covers the descriptive overview of Ascites, explaining its causes, signs, and symptoms, and pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan.
• The report assesses the disease risk and burden.
• The report provides the segmentation of the disease epidemiology for 7MM by Number of Ascites Cases due to Cirrhosis, Number of Ascites Cases by Malignancies, and Severity-specific Cases of Ascites due to Cirrhosis.

Report Highlights
• 10-Year Forecast of Ascites
• 7MM Coverage
• Number of Ascites Cases due to Cirrhosis
• Number of Ascites Cases by Malignancies
• Severity-specific Cases of Ascites due to Cirrhosis

Key Questions Answered
• What are the disease risk, burdens, and unmet needs of Ascites?
• What is the historical Ascites patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Ascites at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Ascites?
• Out of the countries mentioned above, which country would have the highest patient population of Ascites during the forecast period (2021–2030)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2021–2030)?

Reasons to buy
The Ascites report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM Ascites Epiodemiology.
• Organize sales and marketing efforts by identifying the specific type of Ascites that presents the best opportunities for Ascites therapeutics in each of the markets covered.
• The Ascites epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Ascites epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2018–2030

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Liver Diseases Treatment Industry

  • $ 5450
  • April 2021
  • 194 pages

Abstract: - Global Liver Diseases Treatment Market to Reach $27.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Liver Diseases Treatment estimated at US$13.6 Billion in the year 2020, ...

  • World
  • China
  • Digestive System Disorder
  • Targeted Therapy
  • Industry analysis

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on